Markets

Finance Herald Staff

News and analysis written and edited by The Finance Herald newsroom. Our reporting follows our Editorial Policy; sponsored content is labeled under our Sponsored Content Policy.

Health & Pharma

Agios Pharmaceuticals Faces Stock Plunge as Pyrukynd’s Mixed Sickle Cell Trial Results Spark Regulatory Concerns

Agios Pharmaceuticals experienced a significant stock decline following the release of Phase 3 clinical trial data for its anemia medication Pyrukynd on Wednesday, November 19, 2025. The experimental treatment showed partial success in treating sickle cell disease, achieving one primary endpoint while falling short on another critical measure. The drug,

The Questions Every CRO Should Ask Before Renewing Salesforce CPQ
Technology

The Questions Every CRO Should Ask Before Renewing Salesforce CPQ

Your Salesforce CPQ contract renewal is approaching. For many revenue leaders, this moment triggers a familiar pattern: assess current performance, negotiate pricing, sign for another term, and move on. But 2025 presents a fundamentally different decision landscape. With Salesforce CPQ entering end-of-life status and the broader revenue operations

Technology

Revolutionizing Online Shopping: PayPal and OpenAI Integrate Payments into ChatGPT for Seamless Transactions

In a groundbreaking announcement, PayPal has revealed a strategic partnership with OpenAI to integrate its payment services directly into ChatGPT, causing the payment processor’s stock to surge dramatically in premarket trading. The collaboration introduces a revolutionary “chat-to-checkout” feature that promises to transform how users make purchases through